Bank of America
AKRO

Bank of America’s Akero Therapeutics AKRO Stock Holding History

Bank of America’s Portfolio AKRO Stock Details AKRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-49,900
Closed -$2.33M – 7760
2023
Q2 		$2.33M Buy
+49,900
New +$2.29M ﹤0.01% 4092

Other funds holding AKRO

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Bank of America's AKRO Position: Q4 2025 in Review

Bank of America sold out of Akero Therapeutics (AKRO) in Q4 2025, closing a stake of 1,297,438 shares — an estimated $61.6M sold.

Bank of America first reported a position in AKRO in Q3 2019 and held it in 25 quarters. The position peaked at $70.5M in Q2 2025. 2 funds tracked by Wall St. Rank hold AKRO as of Q4 2025.

  • Bank of America reported no remaining Akero Therapeutics position as of Q4 2025 after selling out during the quarter.
  • Bank of America sold 1,297,438 Akero Therapeutics shares in Q4 2025, an estimated $61.6M.
  • Bank of America first reported a position in Akero Therapeutics in Q3 2019 and held it in 25 quarters.
  • Bank of America's Akero Therapeutics position peaked at $70.5M in Q2 2025.
  • 2 funds tracked by Wall St. Rank held Akero Therapeutics as of Q4 2025.

Based on Bank of America's 13F filing for Q4 2025, filed 17 Feb 2026.